FDA Warning Letter — BP

Case 686733 — FEI 3027472809

The FDA took a Warning Letter action against BP on Jun 18, 2024 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Jun 18, 2024
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.